RevitaCAM

Withdrawn

This medicine's authorisation has been withdrawn

meloxicam

Overview

The marketing authorisation for RevitaCAM has been withdrawn at the request of the marketing authorisation holder.

RevitaCAM : EPAR - Summary for the public

Reference Number: EMA/97410/2011

Product information

RevitaCAM : EPAR - Product Information

Latest procedure affecting product information: T/0006

05/10/2015

RevitaCAM : EPAR - All Authorised presentations

Product details

• Name of medicine:
  RevitaCAM
• Active substance:
  meloxicam
• International non-proprietary name (INN) or common name:
  meloxicam
• Species:
  Dogs
• Anatomical therapeutic chemical veterinary (ATCvet) code:
  QM01AC06

Pharmacotherapeutic group

Oxicams

Therapeutic indication

Alleviation of inflammation and pain in both acute and chronic musculoskeletal disorders in dogs.

Authorisation details

• EMA product number:
  EMEA/V/C/002379
• Generic:

  This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.

• Marketing authorisation holder:
  Zoetis Belgium SA

  Rue Laid Burniat 1; 1348 Louvain-la-Neuve; Belgium

• Marketing authorisation issued:
  23/02/2012
• Revision:
  5

Assessment history

Changes since initial authorisation of medicine

RevitaCAM : EPAR - Procedural steps taken and scientific information after authorisation

Initial marketing authorisation documents

RevitaCAM : EPAR - Public assessment report

AdoptedReference Number: EMA/CVMP/37853/2012

CVMP summary of positive opinion for RevitaCAM

AdoptedReference Number: EMA/CVMP/77474/2011